Results 171 to 180 of about 178,738 (259)

Advances in emerging therapies 2006 [PDF]

, 2007
Dawson, J., Lees, K.R.
core   +2 more sources

Knowledge and Attitudes Regarding Pharmacogenetics of Pharmacists in the Netherlands: A National Online Survey Study

Journal of Evaluation in Clinical Practice, Volume 32, Issue 2, March 2026.
ABSTRACT Rationale, Aims and Objectives Pharmacogenetics is considered a promising method to improve pharmacotherapy, yet its implementation in clinical practice is hampered, limiting its potential benefits to the public. Previously, its uptake has been investigated within a variety of healthcare professional groups.
Emma Y. De Brabander, Nicole K. Leibold, Therese van Amelsvoort, Roos van Westrhenen, The PSY‐PGx Consortium, Kristian Kleine Schaars, Sanah Bedi, Allan H. Young, Mario Juruena, Daniel Silman, Urs Heilbronner, Monika Budde, Magnus Ingelman‐Sundberg, Marin Jukic, Martien J. H. Kas, Raj Jagesar, Ramona Moldovan, Markus M. Nöthen, Per Hoffmann, Carina M. Mathey, Alexandra Philipsen, Laura L. Kilarski, Jonathan Laatsch, Noam Shomron, Erik Van der Eycken, Nigel Olisa, Eduard Vieta, Natalia E. Fares‐Otero, Thomas G. Schulze, Therese van Amelsvoort, Bea Campforts, Emma de Brabander, Moritz J. Rossner, Sven P. Wichert, Roos van Westrhenen   +34 more
wiley   +1 more source

Comments on: "Association of Clopidogrel Genetic Polymorphism With Efficacy and Safety for Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Updated Meta-Analysis". [PDF]

J Clin Neurol
Sah SS, Kumbhalwar A.
europepmc   +1 more source

Effect of Spinacia oleracea on In Vitro Disintegration and Dissolution of Clopidogrel Bisulfate Tablets. [PDF]

Pharmacol Res Perspect
Sadaqa D, Naseef HA, Radwan A, Rabba AK, Muqedi RHM.   +4 more
europepmc   +1 more source

Influence of Chronic Kidney Disease on Platelet Reactivity Response to Clopidogrel and Ticagrelor. [PDF]

Int J Mol Sci
Franci A, Giraldez R, Barbosa C, Dalçóquio T, Genestreti P, Ferrari A, Menezes F, Furtado R, Sarti D, Baracioli L, Nicolau J.   +10 more
europepmc   +1 more source

Efficacy and Safety of Clopidogrel Versus Aspirin Monotherapy After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis. [PDF]

Clin Med Insights Cardiol
Cheema AH, Hassan Waseem M, Abideen ZU, Tahir MZ, Saleem F, Nadeem A, Tauseef U, Qasim T, Aimen S, Zahid MB, Thada PK.   +10 more
europepmc   +1 more source

CYP2C19 genotype-guided escalation to ticagrelor vs. clopidogrel in secondary stroke prevention: a retrospective cohort study. [PDF]

Front Pharmacol
Haidong S, Min D, Hong Y, Jing Y.
europepmc   +1 more source

Clopidogrel-induced drug-induced hypersensitivity syndrome following percutaneous coronary intervention: a case report of therapeutic dilemma and management strategy. [PDF]

Front Pharmacol
Wang S, Zhou J, Sun Y.
europepmc   +1 more source

Effect of insulin resistance on ticagrelor-versus clopidogrel-based dual antiplatelet therapy for secondary prevention of stroke in carriers of <i>CYP2C19</i> loss-of-function mutations. [PDF]

CMAJ
Zhao J, Tian X, Yang X, Xu Q, Xia X, Zhang Y, Xie X, Bath PM, Jing J, Wang Y, Meng X, Wang A.   +11 more
europepmc   +1 more source

Response to Tutorial Drug–Drug Interactions by EM Sellers

Clinical and Translational Science, Volume 19, Issue 3, March 2026.
Jesmin Lohy Das, Antoinette (Toni) Ajavon‐Hartmann, Virginia (Ginny) D. Schmith   +2 more
wiley   +1 more source